Hisamitsu’s $2.55 Billion Buyout Is a Classic Japan Inc. Move
Hisamitsu Pharmaceutical is planning a massive management buyout to take the company private. The nearly $2.55 billion deal offers a 35% premium to shareholders and highlights a major trend in Japan’s corporate landscape.












































